期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脊髓小脑性共济失调20例的临床研究 被引量：2

下载PDF
导出
摘要 目的探讨脊髓小脑性共济失调(SCA)的临床特征。方法对脊髓小脑性共济失调20例病人的临床特点和辅助检查进行综合分析。结果SCA多于30岁～40岁隐袭起病,多有家族史,下肢共济失调为首发症状,检查可见肌张力障碍、腱反射亢进、病理征、位置觉及震动觉受损,磁共振成像(MRI)、电生理等有助诊断。结论根据临床特点、结合MRI、神经电生理等辅助检查能够提高临床确诊率。
作者 刘业松 王强庆 王洁蕊 王小洁 刘颖 张辉
机构地区 华北煤炭医学院附属开滦医院神经内科 华北煤炭医学院
出处 《实用心脑肺血管病杂志》 2007年第5期373-374,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 脊髓小脑性共济失调 遗传性共济失调 临床研究
分类号 R744.7 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献4

二级参考文献23

  • 1Herman - Bert A, Stovanin G, Netter JC, et al. Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3 - q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet, 2000, 67 (1) : 229-235.
  • 2Yanashita I, Sasaki H, Yabe I, et al. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2 - cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4 - qter. Ann Neurol, 2000, 48(2) : 156-163.
  • 3Nakamura K, Jeong SY, Ichikawa Y, et al. SCA13, a novel autosomal dominant cerehellar ataxia caused by the expanded polyglutamine in TATA-binding protein identifide with IC2 antibody immunoscreening. Am J Hum Genet, 2000, 67(2): 389.
  • 4Miyoshi Y, Yamada T, Tanimura M, et al. A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-24.1. Neurology, 2001, 57(1): 96-100.
  • 5Koichiro N, Seon - Yong J, Toshiki U, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA- binding protein. Hum Mol Genet, 2001, 10 (14): 1441-1448.
  • 6Gene Tests. Available at: http://www.genetests.org/. Accessed November 16, 2000.
  • 7Tan EK, Ashizawa T. Genetic testing in spinocerebellar ataxias. Arch Neurol, 2001, 58(2): 191- 195.
  • 8Harrington CA, Rosenow C, Retief J. Monitoring gene expression using microarrays. Curr Opin Microbiol, 2000, 3(3): 285- 291.
  • 9Monckton DG, Cayuela ML, Gould FK, et al. Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males. Hum Mol Genet, 1999, 8(13): 2473-2478.
  • 10Chen M, Ona VO, Li M, et al. Minocycline inhibits caspase- 1 and caspase- 3 expression and delays mortality in a transgenic mouse of Huntington disease. Nat Med, 2000, 6(7): 797-801.

共引文献47

同被引文献23

  • 1黄雨兰,喻良,孙红斌.脊髓小脑性共济失调6型一家系12例报道[J].卒中与神经疾病,2005,12(1):55-55. 被引量：3
  • 2Trouillas P,Takayanagi T,Hallett M,et al.International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome.The Ataxia Neuropharmacology Committee of the World Federation of Neurology[J].J Neurol Sci,1997,145(2):205-211.
  • 3Buchsbaum RJ.Rho activation at a glance[J].J Cell Sci,2007,120(Pt7):1149-1152.
  • 4Watanabe Y,Faraci FM,Heistad DD.Activation of Rho-associated kinase during augmented contraction of the basilar artery to serotonin after subarachnoid hemorrhage[J].Am J Physiol Heart Circ Physiol,2005,288(6):H2653-H2658.
  • 5Rikitake Y,Kim HH,Huang Z,et al.Inhibition of Rho kinase (ROCK)leads to increased cerebraI blood flow and stroke protection[J].Stroke,2005,36(10):2251-2257.
  • 6Zhao J,Zhou D,Guo J,et al.Effect of fasudil hydrochloride,a protein kinase inhibitor,on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage[J].Neurol Med Chir(Tokyo),2006,46(9):421-428.
  • 7Yamashita K,Kotani Y,Nakajima Y,et al.Fasudil,a Rho kinase (ROCK) inhibitor,protect against ischemic neuronal damage in vitro and in vivo by acting directly on neurons[J].Brain Res,2007,1154:215-224.
  • 8Pfitzer G.Invited review:regulation of myosin phosphorylation in smooth muscle[J].J Appl Physiol,2001,91(1):497-503.
  • 9Pearce JD,Li J,Edwards MS,et al.Differential effects of Rho-kinase inhibition on artery wall mass and remodeling[J].J Vasc Surg,2004,39(1):223-228.
  • 10Etienne-Manneville S,Hall A.Rho GTPases in cell biology[J].Nature,2002,420(6916):629-635.

引证文献2

二级引证文献3

实用心脑肺血管病杂志
2007年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部